Works matching Thomas Vaux

Results: 4
    1

    Safety and Efficacy of Bimekizumab in Patients With Active Ankylosing Spondylitis: Three‐Year Results From a Phase IIb Randomized Controlled Trial and Its Open‐Label Extension Study.

    Published in:
    Arthritis & Rheumatology, 2022, v. 74, n. 12, p. 1943, doi. 10.1002/art.42282
    By:
    • Baraliakos, Xenofon;
    • Deodhar, Atul;
    • Dougados, Maxime;
    • Gensler, Lianne S.;
    • Molto, Anna;
    • Ramiro, Sofia;
    • Kivitz, Alan J.;
    • Poddubnyy, Denis;
    • Oortgiesen, Marga;
    • Vaux, Thomas;
    • Fleurinck, Carmen;
    • Shepherd‐Smith, Julie;
    • de la Loge, Christine;
    • de Peyrecave, Natasha;
    • van der Heijde, Désirée
    Publication type:
    Article
    2
    3

    Minimal Impact of the COVID‐19 Pandemic on Disease Activity and Health‐Related Quality of Life in Patients With Ankylosing Spondylitis Receiving Bimekizumab: Exploratory Analyses From a Phase 2b Open‐Label Extension Study.

    Published in:
    ACR Open Rheumatology, 2022, v. 4, n. 9, p. 819, doi. 10.1002/acr2.11486
    By:
    • Robinson, Philip C.;
    • Machado, Pedro M.;
    • Haroon, Nigil;
    • Gensler, Lianne S.;
    • Reveille, John D.;
    • Taieb, Vanessa;
    • Vaux, Thomas;
    • Fleurinck, Carmen;
    • Oortgiesen, Marga;
    • de Peyrecave, Natasha;
    • Deodhar, Atul
    Publication type:
    Article
    4